Abstract:MYC oncoprotein deregulation is a common catastrophic event in human cancer and limiting its activity restrains tumor development and maintenance, as clearly shown via Omomyc, an MYC-interfering 90 amino acid mini-protein. MYC is a multifunctional transcription factor that regulates many aspects of transcription by RNA polymerase II (RNAPII), such as transcription activation, pause release, and elongation. MYC directly associates with Protein Arginine Methyltransferase 5 (PRMT5), a protein that methylates a variety of targets, including RNAPII at the arginine residue R1810 (R1810me2s), crucial for proper transcription termination and splicing of transcripts. Therefore, we asked whether MYC controls termination as well, by affecting R1810me2S. We show that MYC overexpression strongly increases R1810me2s, while Omomyc, an MYC shRNA, or a PRMT5 inhibitor and siRNA counteract this phenomenon. Omomyc also impairs Serine 2 phosphorylation in the RNAPII carboxyterminal domain, a modification that sustains transcription elongation. ChIP-seq experiments show that Omomyc replaces MYC and reshapes RNAPII distribution, increasing occupancy at promoter and termination sites. It is unclear how this may affect gene expression. Transcriptomic analysis shows that transcripts pivotal to key signaling pathways are both up- or down-regulated by Omomyc, whereas genes directly controlled by MYC and belonging to a specific signature are strongly down-regulated. Overall, our data point to an MYC/PRMT5/RNAPII axis that controls termination via RNAPII symmetrical dimethylation and contributes to rewiring the expression of genes altered by MYC overexpression in cancer cells. It remains to be clarified which role this may have in tumor development.

c-Myc co-ordinates mRNA cap methylation and ribosomal RNA production

Autophagy Regulates Rrna Synthesis

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

m 6 A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2

C-Myc Modulates Microrna Processing Via The Transcriptional Regulation Of Drosha

METTL5, an 18S Rrna-Specific M6a Methyltransferase, Modulates Expression of Stress Response Genes

Regulation of translation by site-specific ribosomal RNA methylation

RNA-mediated MYC multimerization suppresses innate immune signaling

Structural and Functional Control of the Eukaryotic Mrna Decapping Machinery

The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells

A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription Termination

Cap-Specific m6Am Methyltransferase PCIF1/CAPAM Regulates mRNA Stability of RAB23 and CNOT6 through the m6A Methyltransferase Activity

To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity

The CoREST-complex regulates MYC stability and promotes post-transcriptional mRNA splicing in melanoma

N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation

Coupling of histone methylation and RNA processing by the nuclear mRNA cap-binding complex

Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5′ untranslated region

N-6-Methyladenosine Methyltransferase ZCCHC4 Mediates Ribosomal RNA Methylation

The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA

Cap-specific terminal N 6-methylation of RNA by an RNA polymerase II-associated methyltransferase

Multiple Links Between 5-Methylcytosine Content of Mrna and Translation